ID   COPA_HUMAN              Reviewed;        1224 AA.
AC   P53621; Q5T201; Q8IXZ9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Coatomer subunit alpha;
DE   AltName: Full=Alpha-coat protein;
DE            Short=Alpha-COP;
DE   AltName: Full=HEP-COP;
DE            Short=HEPCOP;
DE   Contains:
DE     RecName: Full=Xenin;
DE     AltName: Full=Xenopsin-related peptide;
DE   Contains:
DE     RecName: Full=Proxenin;
GN   Name=COPA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8647451; DOI=10.1016/0378-1119(95)00738-5;
RA   Chow V.T.K., Quek H.H.;
RT   "HEP-COP, a novel human gene whose product is highly homologous to the
RT   alpha-subunit of the yeast coatomer protein complex.";
RL   Gene 169:223-227(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-25 (XENIN).
RC   TISSUE=Gastric mucosa;
RX   PubMed=1429581;
RA   Feurle G.E., Hamscher G., Kusiek R., Meyer H.E., Metzger J.W.;
RT   "Identification of xenin, a xenopsin-related peptide, in the human
RT   gastric mucosa and its effect on exocrine pancreatic secretion.";
RL   J. Biol. Chem. 267:22305-22309(1992).
RN   [6]
RP   PROTEOLYTIC PROCESSING OF COPA TO PRODUCE XENIN.
RX   PubMed=9365789; DOI=10.1017/S0003480097006295;
RA   Chow V.T.K., Quek H.H.;
RT   "Alpha coat protein COPA (HEP-COP): presence of an Alu repeat in cDNA
RT   and identity of the amino terminus to xenin.";
RL   Ann. Hum. Genet. 61:369-373(1997).
RN   [7]
RP   REVIEW ON XENIN.
RX   PubMed=9533652; DOI=10.1016/S0196-9781(97)00378-1;
RA   Feurle G.E.;
RT   "Xenin -- a review.";
RL   Peptides 19:609-615(1998).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-895, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-402, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND THR-185, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   RNA EDITING OF POSITION 164.
RX   PubMed=21835166; DOI=10.1016/j.bbrc.2011.07.075;
RA   Maas S., Godfried Sie C.P., Stoev I., Dupuis D.E., Latona J.,
RA   Porman A.M., Evans B., Rekawek P., Kluempers V., Mutter M.,
RA   Gommans W.M., Lopresti D.;
RT   "Genome-wide evaluation and discovery of vertebrate A-to-I RNA editing
RT   sites.";
RL   Biochem. Biophys. Res. Commun. 412:407-412(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-402, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173; THR-591 AND
RP   SER-1193, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-895, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-965, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [22]
RP   INTERACTION WITH JAGN1.
RX   PubMed=25129144; DOI=10.1038/ng.3069;
RA   Boztug K., Jaervinen P.M., Salzer E., Racek T., Moench S.,
RA   Garncarz W., Gertz E.M., Schaeffer A.A., Antonopoulos A., Haslam S.M.,
RA   Schieck L., Puchalka J., Diestelhorst J., Appaswamy G., Lescoeur B.,
RA   Giambruno R., Bigenzahn J.W., Elling U., Pfeifer D., Conde C.D.,
RA   Albert M.H., Welte K., Brandes G., Sherkat R.,
RA   van der Werff Ten Bosch J., Rezaei N., Etzioni A.,
RA   Bellanne-Chantelot C., Superti-Furga G., Penninger J.M., Bennett K.L.,
RA   von Blume J., Dell A., Donadieu J., Klein C.;
RT   "JAGN1 deficiency causes aberrant myeloid cell homeostasis and
RT   congenital neutropenia.";
RL   Nat. Genet. 46:1021-1027(2014).
RN   [23]
RP   INVOLVEMENT IN AILJK, VARIANTS AILJK ASN-230; HIS-233; LYS-241 AND
RP   GLY-243, AND CHARACTERIZATION OF VARIANTS AILJK ASN-230 AND LYS-241.
RX   PubMed=25894502; DOI=10.1038/ng.3279;
RG   Baylor-Hopkins Center for Mendelian Genomics;
RA   Watkin L.B., Jessen B., Wiszniewski W., Vece T.J., Jan M., Sha Y.,
RA   Thamsen M., Santos-Cortez R.L., Lee K., Gambin T., Forbes L.R.,
RA   Law C.S., Stray-Pedersen A., Cheng M.H., Mace E.M., Anderson M.S.,
RA   Liu D., Tang L.F., Nicholas S.K., Nahmod K., Makedonas G.,
RA   Canter D.L., Kwok P.Y., Hicks J., Jones K.D., Penney S.,
RA   Jhangiani S.N., Rosenblum M.D., Dell S.D., Waterfield M.R., Papa F.R.,
RA   Muzny D.M., Zaitlen N., Leal S.M., Gonzaga-Jauregui C., Boerwinkle E.,
RA   Eissa N.T., Gibbs R.A., Lupski J.R., Orange J.S., Shum A.K.;
RT   "COPA mutations impair ER-Golgi transport and cause hereditary
RT   autoimmune-mediated lung disease and arthritis.";
RL   Nat. Genet. 47:654-660(2015).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: The coatomer is a cytosolic protein complex that binds
CC       to dilysine motifs and reversibly associates with Golgi non-
CC       clathrin-coated vesicles, which further mediate biosynthetic
CC       protein transport from the ER, via the Golgi up to the trans Golgi
CC       network. Coatomer complex is required for budding from Golgi
CC       membranes, and is essential for the retrograde Golgi-to-ER
CC       transport of dilysine-tagged proteins. In mammals, the coatomer
CC       can only be recruited by membranes associated to ADP-ribosylation
CC       factors (ARFs), which are small GTP-binding proteins; the complex
CC       also influences the Golgi structural integrity, as well as the
CC       processing, activity, and endocytic recycling of LDL receptors (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: Xenin stimulates exocrine pancreatic secretion. It
CC       inhibits pentagastrin-stimulated secretion of acid, to induce
CC       exocrine pancreatic secretion and to affect small and large
CC       intestinal motility. In the gut, xenin interacts with the
CC       neurotensin receptor.
CC   -!- SUBUNIT: Oligomeric complex that consists of at least the alpha,
CC       beta, beta', gamma, delta, epsilon and zeta subunits. Probably
CC       interacts with PEX11A. Interacts with SCYL1 (By similarity).
CC       Interacts with JAGN1. {ECO:0000250, ECO:0000269|PubMed:25129144}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Golgi apparatus
CC       membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC       Cytoplasmic side {ECO:0000250}. Cytoplasmic vesicle, COPI-coated
CC       vesicle membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=The coatomer
CC       is cytoplasmic or polymerized on the cytoplasmic side of the
CC       Golgi, as well as on the vesicles/buds originating from it.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Xenin: Secreted {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P53621-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P53621-2; Sequence=VSP_035043;
CC   -!- TISSUE SPECIFICITY: Uniformly expressed in a wide range of adult
CC       and fetal tissues. Xenin is found in gastric, duodenal and jejunal
CC       mucosa. Circulates in the blood. Seems to be confined to specific
CC       endocrine cells.
CC   -!- DEVELOPMENTAL STAGE: Xenin is released into the circulation after
CC       a meal.
CC   -!- RNA EDITING: Modified_positions=164 {ECO:0000269|PubMed:21835166};
CC       Note=Edited at about 31%.;
CC   -!- DISEASE: Autoimmune interstitial lung, joint, and kidney disease
CC       (AILJK) [MIM:616414]: An autoimmune disease characterized by
CC       inflammatory arthritis, interstitial lung disease, and immune
CC       complex-mediated renal disease. {ECO:0000269|PubMed:25894502}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Xenin entry;
CC       URL="https://en.wikipedia.org/wiki/Xenin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U24105; AAB70879.1; -; mRNA.
DR   EMBL; AL513282; CAI12454.1; -; Genomic_DNA.
DR   EMBL; AL445230; CAI12454.1; JOINED; Genomic_DNA.
DR   EMBL; AL513282; CAI12455.1; -; Genomic_DNA.
DR   EMBL; AL445230; CAI12455.1; JOINED; Genomic_DNA.
DR   EMBL; AL445230; CAI15004.1; -; Genomic_DNA.
DR   EMBL; AL513282; CAI15004.1; JOINED; Genomic_DNA.
DR   EMBL; AL445230; CAI15005.1; -; Genomic_DNA.
DR   EMBL; AL513282; CAI15005.1; JOINED; Genomic_DNA.
DR   EMBL; CH471121; EAW52723.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52725.1; -; Genomic_DNA.
DR   EMBL; BC038447; AAH38447.1; -; mRNA.
DR   CCDS; CCDS1202.1; -. [P53621-1]
DR   CCDS; CCDS41424.1; -. [P53621-2]
DR   PIR; JC4668; ERHUAH.
DR   RefSeq; NP_001091868.1; NM_001098398.1. [P53621-2]
DR   RefSeq; NP_004362.2; NM_004371.3. [P53621-1]
DR   UniGene; Hs.162121; -.
DR   UniGene; Hs.685025; -.
DR   ProteinModelPortal; P53621; -.
DR   BioGrid; 107709; 87.
DR   IntAct; P53621; 63.
DR   MINT; MINT-1144184; -.
DR   STRING; 9606.ENSP00000357048; -.
DR   iPTMnet; P53621; -.
DR   PhosphoSitePlus; P53621; -.
DR   SwissPalm; P53621; -.
DR   BioMuta; COPA; -.
DR   DMDM; 205371746; -.
DR   EPD; P53621; -.
DR   MaxQB; P53621; -.
DR   PaxDb; P53621; -.
DR   PeptideAtlas; P53621; -.
DR   PRIDE; P53621; -.
DR   Ensembl; ENST00000241704; ENSP00000241704; ENSG00000122218. [P53621-1]
DR   Ensembl; ENST00000368069; ENSP00000357048; ENSG00000122218. [P53621-2]
DR   GeneID; 1314; -.
DR   KEGG; hsa:1314; -.
DR   UCSC; uc001fvv.5; human. [P53621-1]
DR   CTD; 1314; -.
DR   DisGeNET; 1314; -.
DR   GeneCards; COPA; -.
DR   HGNC; HGNC:2230; COPA.
DR   HPA; HPA028024; -.
DR   MalaCards; COPA; -.
DR   MIM; 601924; gene.
DR   MIM; 616414; phenotype.
DR   neXtProt; NX_P53621; -.
DR   OpenTargets; ENSG00000122218; -.
DR   PharmGKB; PA26746; -.
DR   eggNOG; KOG0292; Eukaryota.
DR   eggNOG; ENOG410XPZS; LUCA.
DR   GeneTree; ENSGT00870000136519; -.
DR   HOGENOM; HOG000195913; -.
DR   HOVERGEN; HBG005379; -.
DR   InParanoid; P53621; -.
DR   KO; K05236; -.
DR   OMA; KSLFMQT; -.
DR   OrthoDB; EOG091G00SH; -.
DR   PhylomeDB; P53621; -.
DR   TreeFam; TF105693; -.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   SignaLink; P53621; -.
DR   ChiTaRS; COPA; human.
DR   GeneWiki; COPA_(gene); -.
DR   GenomeRNAi; 1314; -.
DR   PRO; PR:P53621; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000122218; -.
DR   CleanEx; HS_COPA; -.
DR   Genevisible; P53621; HS.
DR   GO; GO:0030126; C:COPI vesicle coat; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IBA:GO_Central.
DR   GO; GO:0006891; P:intra-Golgi vesicle-mediated transport; IBA:GO_Central.
DR   GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central.
DR   GO; GO:0030157; P:pancreatic juice secretion; IDA:MGI.
DR   GO; GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IBA:GO_Central.
DR   Gene3D; 1.25.40.10; -; 2.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR024977; Apc4_WD40_dom.
DR   InterPro; IPR016391; Coatomer_asu.
DR   InterPro; IPR010714; Coatomer_asu_C.
DR   InterPro; IPR006692; Coatomer_WD-assoc_reg.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR011048; Haem_d1.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF12894; ANAPC4_WD40; 1.
DR   Pfam; PF04053; Coatomer_WDAD; 1.
DR   Pfam; PF06957; COPI_C; 1.
DR   Pfam; PF00400; WD40; 3.
DR   PIRSF; PIRSF003354; Coatomer_alpha_subunit; 1.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; SSF50978; 2.
DR   SUPFAM; SSF51004; SSF51004; 3.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Disease mutation;
KW   ER-Golgi transport; Golgi apparatus; Hormone; Membrane; Methylation;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Repeat; RNA editing; Secreted; Transport; WD repeat.
FT   CHAIN         1   1224       Coatomer subunit alpha.
FT                                /FTId=PRO_0000223307.
FT   PEPTIDE       1     35       Proxenin.
FT                                /FTId=PRO_0000041400.
FT   PEPTIDE       1     25       Xenin.
FT                                /FTId=PRO_0000041401.
FT   REPEAT        3     38       WD 1.
FT   REPEAT       42     80       WD 2.
FT   REPEAT       84    122       WD 3.
FT   REPEAT      126    164       WD 4.
FT   REPEAT      195    234       WD 5.
FT   REPEAT      241    278       WD 6.
FT   REPEAT      282    319       WD 7.
FT   MOD_RES     173    173       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     185    185       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     402    402       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     591    591       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     895    895       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     965    965       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1193   1193       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     509    509       H -> HEHSCPLPLT (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035043.
FT   VARIANT     164    164       I -> V (in RNA edited version).
FT                                /FTId=VAR_066525.
FT   VARIANT     230    230       K -> N (in AILJK; causes a defect in
FT                                retrograde transport from the Golgi to
FT                                the endoplasmic reticulum;
FT                                dbSNP:rs864309710).
FT                                {ECO:0000269|PubMed:25894502}.
FT                                /FTId=VAR_073844.
FT   VARIANT     233    233       R -> H (in AILJK; dbSNP:rs794727993).
FT                                {ECO:0000269|PubMed:25894502}.
FT                                /FTId=VAR_073845.
FT   VARIANT     241    241       E -> K (in AILJK; causes a defect in
FT                                retrograde transport from the Golgi to
FT                                the endoplasmic reticulum;
FT                                dbSNP:rs794727995).
FT                                {ECO:0000269|PubMed:25894502}.
FT                                /FTId=VAR_073846.
FT   VARIANT     243    243       D -> G (in AILJK; dbSNP:rs794727994).
FT                                {ECO:0000269|PubMed:25894502}.
FT                                /FTId=VAR_073847.
FT   VARIANT    1040   1040       V -> G (in dbSNP:rs34997807).
FT                                /FTId=VAR_033803.
FT   CONFLICT    703    703       L -> V (in Ref. 1; AAB70879).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1224 AA;  138346 MW;  5A8BC35CE78F155D CRC64;
     MLTKFETKSA RVKGLSFHPK RPWILTSLHN GVIQLWDYRM CTLIDKFDEH DGPVRGIDFH
     KQQPLFVSGG DDYKIKVWNY KLRRCLFTLL GHLDYIRTTF FHHEYPWILS ASDDQTIRVW
     NWQSRTCVCV LTGHNHYVMC AQFHPTEDLV VSASLDQTVR VWDISGLRKK NLSPGAVESD
     VRGITGVDLF GTTDAVVKHV LEGHDRGVNW AAFHPTMPLI VSGADDRQVK IWRMNESKAW
     EVDTCRGHYN NVSCAVFHPR QELILSNSED KSIRVWDMSK RTGVQTFRRD HDRFWVLAAH
     PNLNLFAAGH DGGMIVFKLE RERPAYAVHG NMLHYVKDRF LRQLDFNSSK DVAVMQLRSG
     SKFPVFNMSY NPAENAVLLC TRASNLENST YDLYTIPKDA DSQNPDAPEG KRSSGLTAVW
     VARNRFAVLD RMHSLLIKNL KNEITKKVQV PNCDEIFYAG TGNLLLRDAD SITLFDVQQK
     RTLASVKISK VKYVIWSADM SHVALLAKHA IVICNRKLDA LCNIHENIRV KSGAWDESGV
     FIYTTSNHIK YAVTTGDHGI IRTLDLPIYV TRVKGNNVYC LDRECRPRVL TIDPTEFKFK
     LALINRKYDE VLHMVRNAKL VGQSIIAYLQ KKGYPEVALH FVKDEKTRFS LALECGNIEI
     ALEAAKALDD KNCWEKLGEV ALLQGNHQIV EMCYQRTKNF DKLSFLYLIT GNLEKLRKMM
     KIAEIRKDMS GHYQNALYLG DVSERVRILK NCGQKSLAYL TAATHGLDEE AESLKETFDP
     EKETIPDIDP NAKLLQPPAP IMPLDTNWPL LTVSKGFFEG TIASKGKGGA LAADIDIDTV
     GTEGWGEDAE LQLDEDGFVE ATEGLGDDAL GKGQEEGGGW DVEEDLELPP ELDISPGAAG
     GAEDGFFVPP TKGTSPTQIW CNNSQLPVDH ILAGSFETAM RLLHDQVGVI QFGPYKQLFL
     QTYARGRTTY QALPCLPSMY GYPNRNWKDA GLKNGVPAVG LKLNDLIQRL QLCYQLTTVG
     KFEEAVEKFR SILLSVPLLV VDNKQEIAEA QQLITICREY IVGLSVETER KKLPKETLEQ
     QKRICEMAAY FTHSNLQPVH MILVLRTALN LFFKLKNFKT AATFARRLLE LGPKPEVAQQ
     TRKILSACEK NPTDAYQLNY DMHNPFDICA ASYRPIYRGK PVEKCPLSGA CYSPEFKGQI
     CRVTTVTEIG KDVIGLRISP LQFR
//
